This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Arnica chamissonis
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
North American arnica species used as a sustainable substitute for protected Arnica montana.
North American arnica species used as a sustainable substitute for protected Arnica montana. Key active compounds include helenalin, dihydrohelenalin, sesquiterpene lactones.
helenalin, along with dihydrohelenalin and sesquiterpene lactones, are the primary bioactive compounds in Arnica chamissonis. These compounds modulates NF-κB and COX-2 inflammatory pathways, acts on pain pathways via anti-inflammatory and neuroactive effects.
Anti-inflammatory
Supported by clinical evidence; more large-scale trials would strengthen findings
Analgesic
Supported by clinical evidence; more large-scale trials would strengthen findings
Antihematoma
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Vulnerary
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Bruises
Based on traditional use; clinical evidence limited
Muscle pain
Based on traditional use; clinical evidence limited
Sprains
Based on traditional use; clinical evidence limited
Arthritis
Based on traditional use; clinical evidence limited
Found an error or have a correction for Arnica chamissonis?
Report an Issue →